Review
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 15, 2000; 6(4): 465-469
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.465
Molecular biology of liver disorders: the hepatitis C virus and molecular targets for drug development
Howard J. Worman, Feng Lin
Howard J. Worman, Feng Lin, Departments of Medicine and of Anatomy and Cell Biology, College of Physi cians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 100 32, USA
Howard J. Worman is Associate Professor of Medicine and Anatomy and Cell Biology at Columbia University’s College of Physicians and Surgeons and Director of the Division of Digestive and Liver Diseases of the Medical Service at the New York-Presbyterian Hospital Columbia-Presbyterian Campus. He has over 70 scientific papers as well as publications on liver diseases for the lay audience.
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Howard J. Worman, Depar tment of Medicine, College of Physi cians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA. hjw14@columbia.edu
Telephone: +1-212-3058156 Fax: +1-212-3056443
Received: May 25, 2000
Revised: June 12, 1999
Accepted: June 15, 2000
Published online: August 15, 2000
Abstract